Quidel Corporation (United States)

Quidel Corporation (United States)

QuidelOrtho Corporation is a major American manufacturer of diagnostic healthcare products that are sold worldwide.On May 8, 2020 the U.S. Food and Drug Administration has issued the first emergency use authorization for a COVID-19 antigen test, a new category of tests for use in the ongoing pandemic. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Quidel Corporation (United States), United States, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

59%


Total
Publications

63


Total Open
Publications

37


Total
Citations

1.2K


Open Access
Percentage

59%


Total
Publications

63


Total Open
Publications

37


Total
Citations

1.2K

Wikipedia

Website

download

Breakdown

24% 21% 14% 41%

Publisher Open

24%

Both

21%

Other Platform Open

14%

Closed

41%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

01234567891011Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

32%OA Journal

OA Journal 32%

9

Hybrid 25%

7

No Guarantees 43%

12

Other Platform Open

Domain 73%

16

Institution 27%

6

Other Internet 27%

6

Preprint 14%

3

Public 5%

1

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
16
Europe PMC
Domain
9
DOI
Other Internet
3
medRxiv
Preprint
2
CiteSeer X
Other Internet
2
University of North Carolina at Chapel Hill - Carolina Digital Repository
Institution
1
University of Cambridge - Apollo
Institution
1
University of California - eScholarship University of California
Institution
1
The University of Manchester - Research Explorer
Institution
1
The University of Glasgow - Enlighten: Publications
Institution
1
1 / 2

Data updated 25 January 2024

Share

Share

Share